Intensity Therapeutics, Inc.
INTS
$0.41
$0.0515.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.82% | 16.56% | -8.74% | -54.37% | -83.17% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -9.51% | -2.24% | -46.69% | -17.28% | -33.30% |
| Change in Net Operating Assets | -454.24% | 53.08% | 83.41% | -231.91% | 101.83% |
| Cash from Operations | 29.62% | 24.31% | -20.37% | -111.24% | -71.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 211.95% | 211.98% | 205.50% | 203.74% |
| Cash from Investing | -100.00% | 211.95% | 211.98% | 205.50% | 203.74% |
| Total Debt Issued | -- | -- | -- | -- | -100.52% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,984.39% | -61.92% | -82.70% | -84.19% | -97.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,121.95% | 17.96% | 70.00% | 70.76% | 96.33% |
| Cash from Financing | 3,254.01% | -66.08% | -84.12% | -85.83% | -98.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 209.53% | -133.01% | -195.43% | -182.36% | -165.23% |